氨曲南（商品名包括Azactam）是一种抗生素，主要用于治疗由革兰氏阴性细菌（如铜绿假单胞菌）引起的感染。这可能包括骨感染、子宫内膜炎、腹腔内感染、肺炎、尿路感染和败血症。它通过静脉或肌肉注射或吸入给药。

In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in conjunction with metronidazole for people aged 18 and over with complicated ...

Find all the commercial and brand names of generic drug called Aztreonam. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

Purpose The pharmacology, safety, efficacy, pharmacokinetics, pharmacodynamics, current place in therapy, and potential future therapeutic uses of inhaled aztreonam are reviewed. Conclusion ...

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...

aeruginosa infection can often receive adequate MSSA coverage with antipseudomonal agents (with the exception of ceftazidime and aztreonam). The intravenous options for MRSA are generally limited ...

based on the results of the earlier TARGET study which showed non-inferiority for the drug compared to vancomycin plus aztreonam. If it gets a green light, it will be the first antibiotic in the ...